US4851521A
(en)
*
|
1985-07-08 |
1989-07-25 |
Fidia, S.P.A. |
Esters of hyaluronic acid
|
US5202431A
(en)
*
|
1985-07-08 |
1993-04-13 |
Fidia, S.P.A. |
Partial esters of hyaluronic acid
|
US5227157A
(en)
*
|
1986-10-14 |
1993-07-13 |
Board Of Regents, The University Of Texas System |
Delivery of therapeutic agents
|
US5403592A
(en)
*
|
1987-08-25 |
1995-04-04 |
Macnaught Pty Limited |
Lubricant composition for rheumatism
|
IT1219587B
(it)
*
|
1988-05-13 |
1990-05-18 |
Fidia Farmaceutici |
Polisaccaridi carbossiilici autoreticolati
|
US5470829A
(en)
*
|
1988-11-17 |
1995-11-28 |
Prisell; Per |
Pharmaceutical preparation
|
US5783691A
(en)
*
|
1989-02-08 |
1998-07-21 |
Biomatrix, Inc. |
Crosslinked hyaluronate gels, their use and method for producing them
|
CA1340994C
(en)
*
|
1989-09-21 |
2000-05-16 |
Rudolf Edgar Dr. Falk |
Treatment of conditions and disease
|
US5824658A
(en)
*
|
1990-09-18 |
1998-10-20 |
Hyal Pharmaceutical Corporation |
Topical composition containing hyaluronic acid and NSAIDS
|
US5990096A
(en)
*
|
1990-09-18 |
1999-11-23 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US5910489A
(en)
*
|
1990-09-18 |
1999-06-08 |
Hyal Pharmaceutical Corporation |
Topical composition containing hyaluronic acid and NSAIDS
|
US5639738A
(en)
*
|
1992-02-20 |
1997-06-17 |
Hyal Pharmaceutical Corporation |
Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
|
CA2061703C
(en)
*
|
1992-02-20 |
2002-07-02 |
Rudolf E. Falk |
Formulations containing hyaluronic acid
|
US5626863A
(en)
*
|
1992-02-28 |
1997-05-06 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
US5462990A
(en)
*
|
1990-10-15 |
1995-10-31 |
Board Of Regents, The University Of Texas System |
Multifunctional organic polymers
|
US5410016A
(en)
*
|
1990-10-15 |
1995-04-25 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
IT1247175B
(it)
*
|
1991-04-19 |
1994-12-12 |
Fidia Spa |
Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
|
US5234914A
(en)
*
|
1991-06-11 |
1993-08-10 |
Patent Biopharmaceutics, Inc. |
Methods of treating hemorrhoids and anorecial disease
|
US6022866A
(en)
*
|
1991-07-03 |
2000-02-08 |
Hyal Pharmaceutical Corporation |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
WO1994007505A1
(en)
*
|
1991-07-03 |
1994-04-14 |
Norpharmco Inc. |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
US5817644A
(en)
*
|
1991-07-03 |
1998-10-06 |
Hyal Pharmaceutical Corporation |
Targeting of dosages of medicine and therapeutic agents
|
US6103704A
(en)
*
|
1991-07-03 |
2000-08-15 |
Hyal Pharmaceutical Corporation |
Therapeutic methods using hyaluronic acid
|
US5792753A
(en)
*
|
1991-07-03 |
1998-08-11 |
Hyal Pharmaceutical Corporation |
Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
|
US5990095A
(en)
*
|
1991-07-03 |
1999-11-23 |
Hyal Pharmaceutical Corporation |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
US5977088A
(en)
*
|
1991-07-03 |
1999-11-02 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
CA2121129A1
(en)
*
|
1991-10-29 |
1993-05-13 |
Patrick Soon-Shiong |
Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
|
IT1254704B
(it)
*
|
1991-12-18 |
1995-10-09 |
Mini Ricerca Scient Tecnolog |
Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
|
US5824335A
(en)
*
|
1991-12-18 |
1998-10-20 |
Dorigatti; Franco |
Non-woven fabric material comprising auto-crosslinked hyaluronic acid derivatives
|
IT1254170B
(it)
*
|
1991-12-18 |
1995-09-11 |
Mini Ricerca Scient Tecnolog |
Membrane composite per la rigenerazione guidata di tessuti
|
CA2061567C
(en)
*
|
1992-02-20 |
1998-02-03 |
Rudolf E. Falk |
Use of hyaluronic acid to repair ischemia reperfusion damage
|
US6147059A
(en)
*
|
1992-02-20 |
2000-11-14 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US6218373B1
(en)
|
1992-02-20 |
2001-04-17 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US6114314A
(en)
*
|
1992-02-21 |
2000-09-05 |
Hyal Pharmaceutical Corp. |
Formulations containing hyaluronic acid
|
US5767106A
(en)
*
|
1992-02-21 |
1998-06-16 |
Hyal Pharmaceutical Corporation |
Treatment of disease and conditions associated with macrophage infiltration
|
WO1993017669A1
(en)
|
1992-02-28 |
1993-09-16 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
US5573934A
(en)
*
|
1992-04-20 |
1996-11-12 |
Board Of Regents, The University Of Texas System |
Gels for encapsulation of biological materials
|
IT1259090B
(it)
|
1992-04-17 |
1996-03-11 |
Fidia Spa |
Biomaterialli per protesi d'osso
|
IT1259100B
(it)
*
|
1992-05-20 |
1996-03-11 |
Lanfranco Callegaro |
Uso di idrogeli per il bloccaggio di sistemi protesici
|
IT1260154B
(it)
*
|
1992-07-03 |
1996-03-28 |
Lanfranco Callegaro |
Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn)
|
US5550112A
(en)
*
|
1992-12-30 |
1996-08-27 |
Patent Biopharmaceutics, Inc. |
Hyaluronic acid-urea pharmaceutical compositions and uses
|
JP2995090B2
(ja)
*
|
1993-03-19 |
1999-12-27 |
キユー・メド・アクチエボラーグ |
組織増大のための組成物および方法
|
US6005019A
(en)
*
|
1993-07-21 |
1999-12-21 |
United States Surgical Corporation |
Plasticizers for fibers used to form surgical devices
|
CA2127636C
(en)
*
|
1993-07-21 |
2009-10-20 |
Cheng-Kung Liu |
Plasticizers for fibers used to form surgical devices
|
IT1263394B
(it)
*
|
1993-07-30 |
1996-08-05 |
Fidia Advanced Biopolymers Srl |
Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati
|
US5624915A
(en)
*
|
1993-08-04 |
1997-04-29 |
Patent Biopharmaceutics, Inc. |
Hyaluronic acid-urea pharmaceutical compositions and uses
|
US5531716A
(en)
*
|
1993-09-29 |
1996-07-02 |
Hercules Incorporated |
Medical devices subject to triggered disintegration
|
US5399358A
(en)
*
|
1993-11-12 |
1995-03-21 |
Edward Mendell Co., Inc. |
Sustained release formulations for 24 hour release of metroprolol
|
US5399362A
(en)
*
|
1994-04-25 |
1995-03-21 |
Edward Mendell Co., Inc. |
Once-a-day metoprolol oral dosage form
|
DE69534575T2
(de)
*
|
1994-04-25 |
2006-07-13 |
Penwest Pharmaceuticals Co. |
Trägerstoff zur verzögerten Freisetzung
|
US5690961A
(en)
*
|
1994-12-22 |
1997-11-25 |
Hercules Incorporated |
Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
|
PL182804B1
(pl)
*
|
1995-02-07 |
2002-03-29 |
Fidia Advanced Biopolymers |
Sposób powlekania powierzchni przedmiotu kwasem hialuronowym lub pochodną kwasu hialuronowego i sposób powlekania powierzchni przedmiotu polimerem półsyntetycznym
|
ATE306903T1
(de)
|
1995-03-24 |
2005-11-15 |
Genzyme Corp |
Verminderung von adhäsionen durch gesteuerte verabreichung von aktivsauerstoffinhibitoren
|
IT1281870B1
(it)
*
|
1995-04-27 |
1998-03-03 |
Fidia Advanced Biopolymers Srl |
Pelle artificiale umana costituita da materiali biocompatibili a base di derivati dell'acido ialuronico
|
IT1281886B1
(it)
*
|
1995-05-22 |
1998-03-03 |
Fidia Advanced Biopolymers Srl |
Processo per la preparazione di idrogel ottenuti da derivati chimici dell'acido ialuronico mediante irradiazioni ultraviolette e loro
|
US7833543B2
(en)
*
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
US6413536B1
(en)
*
|
1995-06-07 |
2002-07-02 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system and medical or surgical device
|
US5968542A
(en)
*
|
1995-06-07 |
1999-10-19 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system as a device
|
US5747058A
(en)
*
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
US5612321A
(en)
*
|
1995-06-22 |
1997-03-18 |
Hercules Incorporated |
Antioxidant grafted polysaccharides
|
US5827937A
(en)
*
|
1995-07-17 |
1998-10-27 |
Q Med Ab |
Polysaccharide gel composition
|
DE69636626T2
(de)
|
1995-07-28 |
2007-08-30 |
Genzyme Corp., Cambridge |
Biologische abbaubare multiblokhydrogene und ihre verwendung wie trägerstoffe fur kontrollierte freisetzung pharmakologisch activen werstoffe und gewebekontaktmaterialen
|
IT1282207B1
(it)
*
|
1995-11-20 |
1998-03-16 |
Fidia Advanced Biopolymers Srl |
Sistemi di coltura di cellule staminali di midollo osseo umano in matrici tridimensionali costituiti da esteri dell'acido ialuronico
|
WO1997026865A1
(en)
*
|
1996-01-29 |
1997-07-31 |
Edward Mendell Co., Inc. |
Sustained release excipient
|
US5939047A
(en)
*
|
1996-04-16 |
1999-08-17 |
Jernberg; Gary R. |
Local delivery of chemotherapeutic agents for treatment of periodontal disease
|
US6060534A
(en)
|
1996-07-11 |
2000-05-09 |
Scimed Life Systems, Inc. |
Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
|
US6368356B1
(en)
|
1996-07-11 |
2002-04-09 |
Scimed Life Systems, Inc. |
Medical devices comprising hydrogel polymers having improved mechanical properties
|
US20050090662A1
(en)
*
|
1997-01-15 |
2005-04-28 |
Beavers Ellington M. |
Method of making free acids from polysaccharide salts
|
US6294170B1
(en)
|
1997-08-08 |
2001-09-25 |
Amgen Inc. |
Composition and method for treating inflammatory diseases
|
WO1998045335A1
(en)
*
|
1997-04-04 |
1998-10-15 |
Fidia Advanced Biopolymers, S.R.L. |
N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
|
IT1291452B1
(it)
|
1997-04-14 |
1999-01-11 |
Fidia Advanced Biopolymers Srl |
Rivestimento a base di acido ialuronico e suoi derivati per la protezione di parti elettroniche da agenti esterni
|
US20060025328A1
(en)
*
|
1997-05-28 |
2006-02-02 |
Burns Patrick J |
Compositions suitable for controlled release of the hormone GnRH and its analogs
|
IT1294797B1
(it)
|
1997-07-28 |
1999-04-15 |
Fidia Advanced Biopolymers Srl |
Uso dei derivati dell'acido ialuronico nella preparazione di biomateriali aventi attivita' emostatica fisica e tamponante
|
ATE295745T1
(de)
|
1997-08-22 |
2005-06-15 |
Denki Kagaku Kogyo Kk |
Hyaluronsäure-gel, verfahren zur dessen herstellung und hyaluronsäure-gel enthaltendes medizinisches material
|
US6503527B1
(en)
|
1997-11-17 |
2003-01-07 |
Haemacure Corporation |
Fibrin sealants or adhesives comprising a hyaluronic acid derivative material
|
ITPD980149A1
(it)
|
1998-06-17 |
1999-12-17 |
Fidia Advanced Biopolymers Srl |
Protesi tridimensionali comprendenti derivati dell'acido ialuronico per riparare o ricostruire i tessuti danneggiati e processo per la
|
US6630457B1
(en)
|
1998-09-18 |
2003-10-07 |
Orthogene Llc |
Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
|
IT1303738B1
(it)
*
|
1998-11-11 |
2001-02-23 |
Aquisitio S P A |
Processo di reticolazione di polisaccaridi carbossilati.
|
IT1303735B1
(it)
*
|
1998-11-11 |
2001-02-23 |
Falorni Italia Farmaceutici S |
Acidi ialuronici reticolati e loro usi medici.
|
DK1140198T3
(da)
|
1999-01-13 |
2008-03-10 |
Alchemia Oncology Pty Ltd |
Anvendelse af hyaluronan til fremstilling af et lægemiddel til forögelse af cytotoksiske lægemidlers virkningsgrad
|
GB9902412D0
(en)
*
|
1999-02-03 |
1999-03-24 |
Fermentech Med Ltd |
Process
|
IT1306644B1
(it)
|
1999-04-08 |
2001-10-02 |
Fidia Advanced Biopolymers Srl |
Strutture tridimensionali comprendenti derivati dell'acido ialuronicoottenibili mediante la tecnica antisolvente supercritico.
|
US6187822B1
(en)
*
|
1999-06-11 |
2001-02-13 |
University Of Medicine & Dentistry Of Nj |
Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
|
AU780363B2
(en)
|
1999-07-28 |
2005-03-17 |
United States Surgical Corporation |
Hyaluronic acid anti-adhesion barrier
|
US7279176B1
(en)
|
1999-09-02 |
2007-10-09 |
Rice University |
Nitric oxide-producing hydrogel materials
|
US7052711B2
(en)
*
|
1999-09-02 |
2006-05-30 |
Rice University |
Nitric oxide-producing hydrogel materials
|
JP4703926B2
(ja)
|
1999-10-15 |
2011-06-15 |
ジェネティクス インスティテュート,エルエルシー |
骨形成蛋白をデリバリーするためのヒアルロン酸の処方
|
EP1110971B1
(en)
*
|
1999-12-14 |
2004-08-11 |
Kibun Food Chemifa Co., Ltd. |
Propylene glycol hyaluronate and agent for external use to skin using the same
|
DE60012866T2
(de)
*
|
1999-12-14 |
2005-09-08 |
Kibun Food Chemifa Co., Ltd. |
Propylenglykolhyaluronat und äusserlich anzuwendendes Hautpflegemittel, das dieses enthält
|
US6710038B1
(en)
|
1999-12-14 |
2004-03-23 |
Kibun Food Chemifa Co., Ltd. |
Emulsification method using propylene glycol hyaluronate
|
DK1265630T3
(da)
*
|
2000-03-24 |
2006-10-09 |
Genentech Inc |
Anvendelse af insulin til behandling af brusksygdomme
|
AUPQ879500A0
(en)
|
2000-07-14 |
2000-08-10 |
Meditech Research Limited |
Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
|
US9066919B2
(en)
|
2000-07-14 |
2015-06-30 |
Alchemia Oncology Pty Limited |
Hyaluronan as a chemo-sensitizer in the treatment of cancer
|
JP2004513080A
(ja)
*
|
2000-08-17 |
2004-04-30 |
マシーンズ インダストリエールズ エタブリッスメンツ |
摂取可能な容器
|
IT1317359B1
(it)
*
|
2000-08-31 |
2003-06-16 |
Fidia Advanced Biopolymers Srl |
Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
|
AU2001296770A1
(en)
*
|
2000-10-06 |
2002-04-15 |
Durect Corporation |
Devices and methods for management of inflammation
|
AU2002239697A1
(en)
*
|
2000-10-24 |
2002-06-03 |
Clear Solutions Biotech, Inc. |
Sodium hyaluronate microspheres
|
US6576226B1
(en)
|
2000-11-17 |
2003-06-10 |
Gary R. Jernberg |
Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
|
US6726898B2
(en)
|
2000-11-17 |
2004-04-27 |
Gary R. Jernberg |
Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
|
US6586493B1
(en)
|
2001-03-07 |
2003-07-01 |
Arizona Board Of Regents Arizona State University |
Polysaccharide-based hydrogels and pre-gel blends for the same
|
AU2002258490A1
(en)
*
|
2001-03-12 |
2003-06-17 |
Clemson University |
Polysaccharide-based polmerizable hydrogels
|
US6913765B2
(en)
|
2001-03-21 |
2005-07-05 |
Scimed Life Systems, Inc. |
Controlling resorption of bioresorbable medical implant material
|
US20030114061A1
(en)
*
|
2001-12-13 |
2003-06-19 |
Kazuhisa Matsuda |
Adhesion preventive membrane, method of producing a collagen single strand, collagen nonwoven fabric and method and apparatus for producing the same
|
JP4879482B2
(ja)
*
|
2002-05-17 |
2012-02-22 |
ワイス・エルエルシー |
骨原性タンパク質を送達するための注入可能な固体ヒアルロン酸キャリア
|
DE10223310A1
(de)
|
2002-05-24 |
2003-12-11 |
Biotronik Mess & Therapieg |
Verfahren zum Beschichten von Implantaten mit einer Polysaccharid-Lage
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
KR100507545B1
(ko)
*
|
2002-09-03 |
2005-08-09 |
주식회사 엘지생명과학 |
히알루론산 유도체 및 그의 제조방법
|
US7407672B2
(en)
*
|
2002-11-04 |
2008-08-05 |
National Heart Center |
Composition derived from biological materials and method of use and preparation
|
WO2004046331A2
(en)
|
2002-11-15 |
2004-06-03 |
Idenix (Cayman) Limited |
2’-branched nucleosides and flaviviridae mutation
|
EP1564220A4
(en)
*
|
2002-11-21 |
2010-03-17 |
Chugai Pharmaceutical Co Ltd |
EXCIPIENT FOR DELAYED RELEASE MEDICINE
|
SI2218448T1
(sl)
*
|
2002-12-13 |
2016-01-29 |
Durect Corporation |
Sistem za oralno dajanje zdravila, ki obsega tekoči nosilec materialov z visoko viskoznostjo
|
US20040185022A1
(en)
*
|
2003-02-19 |
2004-09-23 |
Steven Rubin |
Regimen for acne treatment
|
US7485719B2
(en)
*
|
2003-02-21 |
2009-02-03 |
Terumo Kabushiki Kaisha |
Crosslinkable polysaccharide derivative, process for producing the same, crosslinkable polysaccharide composition, and medical treatment material
|
US20040167480A1
(en)
*
|
2003-02-21 |
2004-08-26 |
Advanced Medical Optics, Inc. |
Administration of multiple viscoelastic solutions with a multi-compartment syringe
|
US8771649B2
(en)
*
|
2003-05-30 |
2014-07-08 |
Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno |
Inducible release vehicles
|
DE10328815A1
(de)
*
|
2003-06-21 |
2005-01-05 |
Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin |
Beschichtungssystem für Implantate zur Erhöhung der Gewebsverträglichkeit
|
CA2534033A1
(fr)
*
|
2003-07-30 |
2005-02-10 |
Anteis S.A. |
Matrice complexe a usage biomedical
|
US7783006B2
(en)
*
|
2003-10-10 |
2010-08-24 |
Xoft, Inc. |
Radiation treatment using x-ray source
|
US20050080313A1
(en)
*
|
2003-10-10 |
2005-04-14 |
Stewart Daren L. |
Applicator for radiation treatment of a cavity
|
GB2408741B
(en)
*
|
2003-12-04 |
2008-06-18 |
Ind Tech Res Inst |
Hyaluronic acid derivative with urethane linkage
|
US8313765B2
(en)
*
|
2003-12-04 |
2012-11-20 |
Industrial Technology Research Institute |
Biodegradable hyaluronic acid derivative, biodegradable polymeric micelle composition and pharmaceutical or bioactive composition
|
US8124120B2
(en)
|
2003-12-22 |
2012-02-28 |
Anika Therapeutics, Inc. |
Crosslinked hyaluronic acid compositions for tissue augmentation
|
EP1711159B1
(en)
*
|
2003-12-30 |
2013-03-20 |
Durect Corporation |
Solid implants containing a block copolymer for controlled release of a gnrh compound
|
NZ549010A
(en)
|
2004-01-07 |
2010-07-30 |
Seikagaku Kogyo Co Ltd |
Hyaluronic acid derivative and drug containing the same
|
WO2005094915A1
(ja)
*
|
2004-03-31 |
2005-10-13 |
Nipro Corporation |
癒着防止用キット、癒着防止用キットの製造方法および癒着防止方法
|
US8293890B2
(en)
|
2004-04-30 |
2012-10-23 |
Advanced Cardiovascular Systems, Inc. |
Hyaluronic acid based copolymers
|
US7651702B2
(en)
*
|
2004-05-20 |
2010-01-26 |
Mentor Corporation |
Crosslinking hyaluronan and chitosanic polymers
|
US20050281880A1
(en)
*
|
2004-05-20 |
2005-12-22 |
Wei Wang |
Methods for making injectable polymer hydrogels
|
US7956180B2
(en)
*
|
2004-05-27 |
2011-06-07 |
Novozymes A/S |
Dried and agglomerated hyaluronic acid product
|
US20080280973A1
(en)
*
|
2004-06-28 |
2008-11-13 |
Wender Paul A |
Laulimalide Analogues as Therapeutic Agents
|
EP2327413A1
(en)
|
2004-07-06 |
2011-06-01 |
ZymoGenetics, Inc. |
Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use
|
ITMI20041373A1
(it)
|
2004-07-09 |
2004-10-09 |
Lima Lto S P A |
N-metil-ammidi di carbossimetilcellulosa acido alginico o carbossimetalamido
|
US8512730B2
(en)
*
|
2004-07-12 |
2013-08-20 |
Isto Technologies, Inc. |
Methods of tissue repair and compositions therefor
|
CA2570521C
(en)
*
|
2004-07-12 |
2013-06-25 |
Isto Technologies, Inc. |
Tissue matrix system
|
US7858107B2
(en)
*
|
2004-09-10 |
2010-12-28 |
Medtronic Xomed, Inc. |
Flexible bioresorbable hemostatic packing and stent having a preselectable in-vivo residence time
|
ES2378671T3
(es)
*
|
2004-09-17 |
2012-04-16 |
Durect Corporation |
Composición anestésica local prolongada que contiene SAIB
|
PT1817347T
(pt)
|
2004-11-24 |
2017-07-21 |
Albumedix As |
Resumo
|
WO2006067608A1
(en)
*
|
2004-12-22 |
2006-06-29 |
Laboratoire Medidom S.A. |
Aqueous formulations based on sodium hyaluronate for parenteral use
|
US20080139501A1
(en)
*
|
2004-12-30 |
2008-06-12 |
Novozymes Biopolymer A/S |
Hyaluronic Acid Linked With a Polymer of an Alpha Hydroxy Acid
|
GB0513552D0
(en)
|
2005-07-01 |
2005-08-10 |
Bristol Myers Squibb Co |
Bandage
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
EP1912658B1
(en)
|
2005-07-27 |
2017-01-25 |
Alchemia Oncology Pty Limited |
Therapeutic protocols using hyaluronan
|
JP5627181B2
(ja)
|
2005-09-07 |
2014-11-19 |
アルケミア オンコロジー ピーティーワイ リミテッド |
ヒアルロナンおよび治療用抗体を含む治療用組成物ならびに治療方法
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
US8444968B2
(en)
*
|
2005-12-07 |
2013-05-21 |
Isto Technologies, Inc. |
Cartilage repair methods
|
CN101511170B
(zh)
*
|
2005-12-22 |
2014-03-26 |
奥克伍德药业有限公司 |
可升华持续释放传递系统和其制造方法
|
US20070280986A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Carlos Gil |
Intra-operative coating of implants
|
JP2009541372A
(ja)
*
|
2006-06-28 |
2009-11-26 |
ノボザイムス バイオファーマ デーコー アクティーゼルスカブ |
複数のヒアルロン酸画分を含む化粧用と医療用の組成物
|
JP5740087B2
(ja)
|
2006-09-13 |
2015-06-24 |
エンハンス スキン プロダクツ,インク. |
スキンケア用化粧品組成物およびその製造方法
|
EP2117521B1
(en)
|
2006-11-03 |
2012-06-27 |
Durect Corporation |
Transdermal delivery systems comprising bupivacaine
|
EP1942117A1
(en)
*
|
2006-12-29 |
2008-07-09 |
Sigea S.R.L. |
Derivatives of acid polysaccharides
|
CN101677952B
(zh)
|
2007-05-18 |
2012-12-05 |
杜雷科特公司 |
改进的贮库制剂
|
NZ581862A
(en)
|
2007-05-25 |
2012-06-29 |
Tolmar Therapeutics Inc |
Injectable subcutaneous formulation comprising risperidone capable of forming a solid, microporous implant in a patient
|
EP2177539A1
(en)
*
|
2007-08-09 |
2010-04-21 |
Kibun Food Chemifa Co., Ltd. |
Propylene glycol hyaluronate ester and external preparation for skin using the same
|
CA2706931C
(en)
|
2007-12-06 |
2015-05-12 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
JP5523338B2
(ja)
*
|
2007-12-19 |
2014-06-18 |
エヴォニク ゴールドシュミット ゲーエムベーハー |
エマルジョン中の架橋ヒアルロン酸
|
JP5722217B2
(ja)
|
2008-09-02 |
2015-05-20 |
アラーガン・ホールディングス・フランス・ソシエテ・パール・アクシオン・サンプリフィエAllergan Holdings France S.A.S. |
ヒアルロン酸および/またはその誘導体の糸、その作製方法、ならびにその使用
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
SI2384210T1
(en)
|
2008-12-02 |
2018-02-28 |
Allergan, Inc. |
Injection device
|
IT1395392B1
(it)
|
2009-08-27 |
2012-09-14 |
Fidia Farmaceutici |
Geli viscoelastici come nuovi filler
|
US8273725B2
(en)
*
|
2009-09-10 |
2012-09-25 |
Genzyme Corporation |
Stable hyaluronan/steroid formulation
|
US8936804B2
(en)
|
2010-01-15 |
2015-01-20 |
Rutgers, The State University Of New Jersey |
Use of vanadium compounds to accelerate bone healing
|
IL206739A
(en)
|
2010-06-30 |
2016-06-30 |
David Segal |
An injectable drug containing silitol as an active substance
|
TWI561535B
(en)
|
2011-10-06 |
2016-12-11 |
Bvw Holding Ag |
Copolymers of hydrophobic and hydrophilic segments that reduce protein adsorption
|
EP3243533B1
(en)
*
|
2011-10-11 |
2020-06-17 |
Allergan Holdings France S.A.S. |
Threads of cross-linked hyaluronic acid and methods of use thereof
|
US9089574B2
(en)
|
2011-11-30 |
2015-07-28 |
Emory University |
Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
|
FR2983483B1
(fr)
|
2011-12-02 |
2014-11-14 |
Vivacy Lab |
Procede de substitution et reticulation simultanees d'un polysaccharide via ses fonctions hydroxyles
|
US10245306B2
(en)
|
2012-11-16 |
2019-04-02 |
Isto Technologies Ii, Llc |
Flexible tissue matrix and methods for joint repair
|
ITMI20130162A1
(it)
*
|
2013-02-06 |
2014-08-07 |
Fidia Farmaceutici |
Derivati fotoreticolati di acido ialuronico, loro processo di preparazione ed impiego
|
US20140308352A1
(en)
|
2013-03-11 |
2014-10-16 |
Zogenix Inc. |
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
|
BR112015022023B1
(pt)
|
2013-03-11 |
2022-12-06 |
Durect Corporation |
Composição de liberação controlada injetável compreendendo transportador líquido de alta viscosidade
|
WO2014165113A1
(en)
*
|
2013-03-12 |
2014-10-09 |
Allergan Holdings France S.A.S. |
Cross-linked hyaluronic acid threads for treatment of striae
|
AU2014233453A1
(en)
|
2013-03-15 |
2015-10-01 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
US20140350518A1
(en)
|
2013-05-23 |
2014-11-27 |
Allergan, Inc. |
Syringe extrusion accessory
|
US9492474B2
(en)
|
2013-07-10 |
2016-11-15 |
Matrix Biology Institute |
Compositions of hyaluronan with high elasticity and uses thereof
|
CN103450368B
(zh)
*
|
2013-07-25 |
2014-05-07 |
山东福瑞达生物工程有限公司 |
一种硅烷化玻璃酸酯复合物的制备方法
|
US10265292B2
(en)
*
|
2013-09-18 |
2019-04-23 |
The Werc Shop, LLC |
Terpene-based compositions, processes methodologies
|
WO2015112912A1
(en)
|
2014-01-27 |
2015-07-30 |
Allergan Holdings France S.A.S. |
Substance delivery device
|
CN111620830A
(zh)
|
2014-03-14 |
2020-09-04 |
北卡罗来纳大学教堂山分校 |
用于抑制雄性生育力的小分子
|
US10029048B2
(en)
|
2014-05-13 |
2018-07-24 |
Allergan, Inc. |
High force injection devices
|
US10226585B2
(en)
|
2014-10-01 |
2019-03-12 |
Allergan, Inc. |
Devices for injection and dosing
|
US10179191B2
(en)
|
2014-10-09 |
2019-01-15 |
Isto Technologies Ii, Llc |
Flexible tissue matrix and methods for joint repair
|
EP3268063A4
(en)
|
2015-03-10 |
2018-10-31 |
Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company |
Multiple needle injector
|
RU2582702C1
(ru)
*
|
2015-08-19 |
2016-04-27 |
федеральное государственное бюджетное учреждение "Федеральный научно-исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "ФНИЦЭМ им. Н.Ф. Гамалеи" Минздрава России) |
Способ получения композиции на основе модифицированного гиалуроната натрия, композиция на основе модифицированного гиалуроната натрия и ее применение
|
PL3352766T3
(pl)
|
2015-09-24 |
2021-08-02 |
Matrix Biology Institute |
Kompozycie z hialuronanem o dużej elastyczności i sposoby ich użycia
|
CN105418803A
(zh)
*
|
2015-12-30 |
2016-03-23 |
山东天晟生物科技有限公司 |
一种透明质酸的酯化方法
|
BR112018070642A2
(pt)
|
2016-04-08 |
2019-02-05 |
Allergan Inc |
dispositivo de aspiração e injeção
|
CN105949478B
(zh)
*
|
2016-05-05 |
2021-10-01 |
宜昌东阳光生化制药有限公司 |
除去交联透明质酸中交联剂的方法
|
US10265151B2
(en)
|
2017-01-24 |
2019-04-23 |
Allergan Industrie Sas |
Thread insertion devices
|
US10595977B2
(en)
|
2017-01-24 |
2020-03-24 |
Allergan Industrie, Sas |
Thread insertion devices
|
US10709444B2
(en)
|
2017-01-24 |
2020-07-14 |
Allergan Industrie Sas |
Thread insertion devices
|
US10258447B2
(en)
|
2017-01-24 |
2019-04-16 |
Allergan Industrie Sas |
Thread insertion devices
|
US10820900B2
(en)
|
2017-01-24 |
2020-11-03 |
Allergan Industrie Sas |
Thread insertion devices
|
IT201700008651A1
(it)
*
|
2017-01-26 |
2018-07-26 |
Beauty System Pharma Ltd |
Acido ialuronico reticolato con agenti reticolanti di tipo naturale o semisintetico
|
USD867582S1
(en)
|
2017-03-24 |
2019-11-19 |
Allergan, Inc. |
Syringe device
|
WO2020212920A1
(en)
*
|
2019-04-19 |
2020-10-22 |
Jointherapeutics Srl |
Crosslinked polymer of functionalized hyaluronic acid and its use in the treatment of inflammatory states
|
CA3167217A1
(en)
|
2020-01-13 |
2021-07-22 |
Durect Corporation |
Sustained release drug delivery systems with reduced impurities and related methods
|
IT202100012737A1
(it)
|
2021-05-18 |
2022-11-18 |
Jointherapeutics S R L |
Miscele di polisaccaridi e poliamminosaccaridi con proprietà reologiche migliorate
|
IT202100013787A1
(it)
|
2021-05-27 |
2022-11-27 |
Farmigea Spa |
Composizione per l’uso nel trattamento di affezioni oculari, quali sindrome dell’occhio secco, specialmente post-chirurgico oftalmico / a composition for use in the treatment of ocular affections, such as dry eye disease, especially after eye surgery
|
CN114085373B
(zh)
*
|
2021-12-09 |
2023-07-14 |
万华化学集团股份有限公司 |
一种透明质酸聚醚多元醇及其制备方法和应用
|
IT202200002000A1
(it)
*
|
2022-02-04 |
2023-08-04 |
Mak Pharma S R L |
Composizione orale liposomiale di almeno un principio attivo scarsamente assorbibile a livello intestinale
|
IT202200004613A1
(it)
|
2022-03-10 |
2023-09-10 |
Cmed Aesthetics S R L |
“procedimento di preparazione di prodotti sterili”
|